Mumbai-headquartered drug maker Wockhardt has entered into an agreement with Russian Direct Investment Fund (RDIF) arm Enso Healthcare to make 620 million doses of the Sputnik V and Sputnik Light vaccines over the next two years.
This is twice the amount of doses Serum Institute of India (SII) will make of the Russian vaccine, and cumulatively will take the Sputnik V manufacturing capacity in India to 1.7 billion doses annually. However, so far RDIF’s partner in India Dr Reddy’s Laboratories (DRL) has been importing the vaccine, and locally manufactured doses are yet to be available.
On Friday Wockhardt said it